18-Methylaminocoronaridine

Source: Wikipedia, the free encyclopedia.
18-Methylaminocoronaridine
JSmol)
  • c4cccc1c4[nH]c3c1CCN2CC(C5)CC3(C(=O)OC)C2C5CCNC
  • InChI=1S/C22H29N3O2/c1-23-9-7-15-11-14-12-22(21(26)27-2)19-17(8-10-25(13-14)20(15)22)16-5-3-4-6-18(16)24-19/h3-6,14-15,20,23-24H,7-13H2,1-2H3/t14-,15+,20+,22-/m1/s1 checkY
  • Key:YKMOJVPLIUXEIP-SVBQBFEESA-N checkY
  (verify)

(−)-18-Methylaminocoronaridine (18-MAC) is a second generation synthetic derivative of ibogaine developed by the research team led by the pharmacologist Stanley D. Glick from the Albany Medical College and the chemist Martin E. Kuehne from the University of Vermont.[1][2]

See also

References

  1. PMID 12801235
    .
  2. PMID 15178360
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=18-Methylaminocoronaridine&oldid=1197776166"